Bristol-Myers Squibb (BMY) Tops Q2 EPS by 2c
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $57.58 -0.62%
Revenue Growth %: -4.6%
Financial Fact:
Marketing, selling and administrative: 1.14B
Today's EPS Names:
CCEL, FEIM, PLG, More
Revenue Growth %: -4.6%
Financial Fact:
Marketing, selling and administrative: 1.14B
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $1.93, $0.02 better than the analyst estimate of $1.91. Revenue for the quarter came in at $11.7 billion versus the consensus estimate of $11.33 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2021 EPS of $7.35-$7.55, versus the consensus of $7.46.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
- Occidental Petroleum releases Q2 2026 earnings considerations
- FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
